Dosed ingredient Cosmetic cross-reference

Sodium Carbonate

CAS 497-19-8

Sodium Carbonate (CAS 497-19-8) is a Phase 4 pharmaceutical compound with 1 bioactivity target and 7 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
1
SOURCE DrugCentral
Adverse signals
7
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Sodium Carbonate
CAS Number
497-19-8
UNII
45P3261C7T
InChIKey
CDBYLPFSWZWCQE-UHFFFAOYSA-L
ChEMBL ID
CHEMBL186314
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
dosed ingredient
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL186314 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- Ki 60000 nM 1 -
SOURCE DrugCentral 7 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Death 88 165.517 10011906
Exposure to toxic agent 22 108.311 10053487
Micropenis 6 51.641 10071706
Renal hypoplasia 6 41.5 10049102
Microphthalmos 6 38.256 10027548
Low set ears 6 35.968 10024929
Retrognathia 6 35.792 10051821

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 4 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
SODIUM CARBONATE 36685 SU MTHSPL
Sodium Carbonate 36685 SU MTHSPL
sodium carbonate 36685 SU MTHSPL
sodium carbonate 36685 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Sodium Carbonate used for in pharmaceutical contexts?

Sodium Carbonate (CAS 497-19-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Sodium Carbonate?

Sodium Carbonate has 7 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Death, Exposure to toxic agent, Micropenis, Renal hypoplasia, Microphthalmos. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Sodium Carbonate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Bicarbonate with EU status "permitted".

What clinical phase is Sodium Carbonate in?

Sodium Carbonate is rendered with ChEMBL max phase 4 (approved).